Results 211 to 220 of about 26,593 (244)
Some of the next articles are maybe not open access.
Targeted radionuclide therapy for neuroendocrine tumours.
Endocrine-related cancer, 2003Evidence supporting the potential contribution of targeted radiotherapy to the management of neuroendocrine tumours is now strong. Acting systemically, this is an effective option for patients with inoperable or multi-site disease. Toxicity is generally low, being limited to reversible myelosuppression and theoretical nephrotoxicity.
openaire +2 more sources
Adverse Events in Targeted Radionuclide Therapy
RadioGraphicsTargeted radionuclide therapy is a rapidly growing field in the era of personalized medicine, and it is vital for physicians to recognize and appropriately manage therapy-related adverse events to deliver safe and effective patient care.
Kip E. Guja +7 more
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
Progress and controversies: Radiation therapy for prostate cancer
Ca-A Cancer Journal for Clinicians, 2014Neil E Martin
exaly